[Special Stock] CareLabs Leads COVID-19 Remote Medical Care with 'Goodoc'... Sale Process Gains Momentum

[Asia Economy Reporter Hyunseok Yoo] CareLabs, a mobile healthcare platform company, is showing strong performance. This is interpreted as a result of increased expectations for the activation of telemedicine as the novel coronavirus infection (COVID-19) spreads worldwide.

As of 11:11 AM on the 18th, CareLabs was traded at 15,750 KRW, up 18.42% (2,450 KRW) compared to the previous trading day.

The government temporarily allowed telemedicine to prevent the spread of COVID-19. CareLabs is responding to the COVID-19 situation based on 'Goodoc,' a nationwide hospital and pharmacy medical information platform. It launched the mask notification service 'Mask Scanner.' As the number one mobile healthcare platform in Korea, it has secured information on domestic medical institutions.

At the end of last month, following the government's temporary approval of telemedicine services due to the impact of COVID-19, CareLabs officially launched the 'Goodoc Telemedicine' service through its representative platform Goodoc.

By using the Goodoc service, when both the patient and the doctor (or pharmacist) agree, all services including prescription issuance (transmission) and medical fee payment can be enjoyed online without visiting a hospital or pharmacy. Before telemedicine services were allowed, face-to-face contact was inevitable.

CareLabs is currently the leading company in the domestic mobile healthcare platform sector. Since its establishment, it has succeeded in securing information on 69,000 hospitals and 23,000 pharmacies over about five years. Based on its database (DB), it is expected to provide differentiated services in the domestic telemedicine market as well.

With growing interest in non-face-to-face service providers due to COVID-19, the sale process of CareLabs is also expected to gain momentum. Daily Blockchain, the seller of CareLabs, and Maple Investment Partners, the buyer, have entered detailed negotiations including the price and transaction conditions of CareLabs.

Among the major limited partners (LPs) of the project fund that Maple Investment Partners will establish to acquire CareLabs is the Green Cross Group. It is known that Green Cross plans to hold a board meeting to finalize the decision to invest in the fund related to the acquisition of CareLabs.

Globally, telemedicine services are rapidly growing. According to Fortune Business Insights, the global telemedicine market size is expected to grow from $49.8 billion (approximately 60 trillion KRW) in 2018 to $266.8 billion (approximately 325 trillion KRW) by 2026.

This content was produced with the assistance of AI translation services.